News
![Lung Cancer.](https://pharmaphorum.com/wp-content/uploads/2018/06/lung-cancer-image.jpg)
Tagrisso paired with Hutchmed drug clears lung cancer test
EGFR inhibitors like AstraZeneca's Tagrisso have been hugely successful in treating EGFR-positive lung cancer, but the durability of treatment is often reduced by resistance mutations.